A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -22.18% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 62.34%. Over the past 30 days, the price of ABVX has fallen by 67.50%. And in the last five days, it has surged by 12.99%.
The stock of Abivax ADR (ABVX) is currently priced at $10.0. In the last session, the stock climbed significantly, topping out at $50.0 after opening at $10.0. The day’s lowest price was $20.0 before the stock closed at $10.14.
Abivax ADR ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $13.17 on 08/30/24, while the lowest value for the same period was recorded at $4.77 on 04/09/25.
52-week price history of ABVX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Abivax ADR’s current trading price is -24.07% away from its 52-week high, while its distance from the 52-week low is 109.64%. The stock’s price range during this period has varied between$4.77 and $13.17. The Abivax ADR’s shares, which operate in the Healthcare, saw a trading volume of around 0.95 million for the day, a figure considerably higher than their average daily volume of 0.33 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Abivax ADR (ABVX) has experienced a quarterly rise of 60.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 634.70M and boasts a workforce of 69 employees.
Abivax ADR: Analysts’ Ratings Unveiled
As of right now, 4 analysts are rating Abivax ADR as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.96, with a change in price of +2.40. Similarly, Abivax ADR recorded 352,403 in trading volume during the last 100 days, posting a change of +31.58%.
ABVX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ABVX stands at 2.37. Similarly, the long-term debt-to-equity ratio is also 1.29.
ABVX Stock Stochastic Average
Abivax ADR’s raw stochastic average for the past 50 days is presently 85.80%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 83.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 87.73% and 90.98%, respectively.
